Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant insulin lispro vs Humalog in diabetes
CTR20170998Phase 3Completed
- Sponsor
- Wanbang Biopharmaceuticals
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin lispro in type 2 diabetes mellitus (T2DM), diabetes mellitus type 1 (T1D), sponsored by Wanbang Biopharmaceuticals. Started Oct 2017; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on CTR20170998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170998.